Skip to content
Med-Tech Startup Challenges & Resources-Duane Mancini-Project MedTech episode artwork

Jan 24, 2022 27 min

Med-Tech Startup Challenges & Resources-Duane Mancini-Project MedTech

from The Med-Tech Talent Lab

I was so excited to host Duane Mancini, the Founder & CEO of Project Med-Tech, primarily because Duane and his team are adding so much value to the industry at large by way of the fantastic content they put out on a regular basis. Duane hosts the Project MedTech podcast where he interviews leading experts in the Medical Device industry on a variety of topics related to major successes, pitfalls, and trends. Recently, Project MedTech has morphed into a full-blown business of resources for Med-Tech startups at any phase the company is working through. For over 10+ years, Duane has held a variety of roles in the Med-Tech industry (Chemist, Sr Technical Advisor, and multiple Business Development roles with companies like NAMSA and LabCor. Duane holds his Bachelors and Masters degrees in Medicinal and Biological Chemistry from the University of Toldeo. Some of the highlights we discussing during this episode: -How Project Medtech support Startups and the resources they can provide -How crucial it is to understand Regulatory, Reimbursement, & Commercialization and how each affects business decisions -The most surprising feedback Duane has received from an Investor's point of view ...and so much more!

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Med-Tech Startup Challenges & Resources-Duane Mancini-Project MedTech

0:00 27:08

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Med-Tech Talent Lab?

This episode is 27 minutes long.

When was this The Med-Tech Talent Lab episode published?

This episode was published on January 24, 2022.

Can I download this The Med-Tech Talent Lab episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.